Phase I Dose-finding and Preliminary Efficacy Study of the Istodax® in Combination With Doxil® for the Treatment of Adults With Relapsed or Refractory Cutaneous T-cell Lymphoma
Clinical trial NCT01902225 · COMPLETED
Trial details
- NCT number
- NCT01902225
- Sponsor
- Weiyun Ai
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-04
- Primary completion
- 2018-07-13
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.